Delivery Order 75F40122D00003-75F40124F19041
- Not listed
- This delivery order, valued at approximately $170,000, was awarded by the Department of Health and Human Services' Food and Drug Administration to Midnight Sun Technologies LLC Virginia Branch Division for bioinformatics services. As a division of Kikiktagruk Inupiat Corp, doing business as K I C, Midnight Sun will provide these services in support of FDA programs in Silver Spring, Maryland over a one year period concluding in late 2024. No major subcontractors or set aside designations were...
- This is a delivery order awarded to Midnight Sun Technologies LLC, a small business subsidiary of Alaskan Native Corporation Kikiktagruk Inupiat Corporation (KIC). The $333,139.92 firm-fixed-price contract was issued by the Food and Drug Administration (FDA) to provide a Bioinformaticist III for scientific support services to the FDA's Division of Epidemiology. The contract has a period of performance through September 6, 2023. Midnight Sun Technologies is an 8(a) Program participant and has...
- This is a $344,486.40 delivery order contract awarded by the Food and Drug Administration (FDA) to Midnight Sun Technologies LLC, a subsidiary of Kikiktagruk Inupiat Corporation (KIC), an Alaska Native Corporation. The contract is for bioinformatics services to support the development of an internal bioinformatics validation pipeline targeting neoantigen cancer vaccine development, which will aid the regulatory program of the FDA's Division of Clinical Trials (DCT) in the Office of Therapeutic...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to Midnight Sun Technologies LLC, a subsidiary of Kikiktagruk Inupiat Corporation (KIC), an Alaska Native Corporation. The contract, valued at $334,091.47, is for scientific support services in the area of bioinformatics. The work will be performed in Takoma Park, Maryland, and has a completion date of September 12, 2023. Midnight Sun Technologies is an 8(a) Program participant, Indian Economic Enterprise, and Small...
- This is a $257,820.80 delivery order awarded to Midnight Sun Technologies LLC, a subsidiary of Alaskan Native Corporation Kikiktagruk Inupiat Corp (K I C), by the Food and Drug Administration (FDA). The contract is for scientific and technical support services, including expertise in areas such as immunology, gene therapy, and regulatory science. This is not a set-aside contract, but Midnight Sun Technologies is an 8(a) Program participant and designated as an Indian Economic Enterprise and...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to Midnight Sun Technologies LLC, a subsidiary of Kikiktagruk Inupiat Corporation (KIC), an Alaskan Native Corporation. The $1,761,188.08 task order is for 5 contracted research personnel under the Scientist III labor category. While the original solicitation is not provided, the award indicates Midnight Sun Technologies is furnishing scientific, technical, and business support services to the FDA, including personnel...
- This is a delivery order awarded to Midnight Sun Technologies LLC, a subsidiary of Kikiktagruk Inupiat Corporation (an Alaskan Native Corporation), to provide scientific support services to the Food and Drug Administration (FDA). The delivery order, valued at $283,677.76, is for a Scientist IV labor category under an existing indefinite-delivery indefinite-quantity (IDIQ) contract. Midnight Sun Technologies is designated as an 8(a) Program participant, Indian Economic Enterprise, and Small...
- This is a delivery order awarded to Midnight Sun Technologies LLC, a subsidiary of Kikiktagruk Inupiat Corporation (KIC), an Alaska Native Corporation. The $161,869.92 firm fixed price task order is funded by the Food and Drug Administration (FDA) under a multiple-award Indefinite Delivery Vehicle (IDV) contract held by Midnight Sun Technologies. The task order is to provide a researcher to support ongoing immunology and bioanalytical research projects for the FDA's Office of Biotechnology...
- This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Midnight Sun Technologies LLC, a subsidiary of Kikiktagruk Inupiat Corporation (KIC), an Alaskan Native Corporation. The contract, valued at $385,904.10, is for the provision of subject matter expert support services across a range of scientific and technical disciplines, including immunology, gene therapy, stem cell research, and regulatory science. Midnight Sun Technologies, which is certified as an 8(a)...
- This is a $182,127.98 delivery order contract awarded by the Food and Drug Administration (FDA) to Midnight Sun Technologies LLC, a subsidiary of Kikiktagruk Inupiat Corporation (KIC), an Alaskan Native Corporation. The contract is to obtain a researcher to support the research program of the FDA's Center for Biologics Evaluation and Research, Office of Tissue and Advanced Therapies, Division of Cellular and Gene Therapies. This contract is not set aside. Midnight Sun Technologies is an 8(a)...
- 75F40122D00003Indefinite Delivery Contract
- 75F40122D00003-75F40124F19041Delivery Order
The Food and Drug Administration awarded a $81,940 delivery order for Bioinformatics III to Midnight Sun Technologies LLC, a Virginia-based subsidiary of Kikiktagruk Inupiat Corporation (KIC), an Alaskan Native Corporation. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 29, 2026, and was issued on July 24, 2024. This award was not set aside for small business preferences, though Midnight Sun Technologies maintains certifications as an 8(a) Program participant, Indian Economic Enterprise, and Small Disadvantaged Business. The work will be performed in Silver Spring, Maryland, supporting FDA operations. This delivery order is issued under the FDA's $25 million single-award IDIQ for scientific support services, which was awarded to Midnight Sun Technologies as an 8(a) sole source contract. The bioinformatics support aligns with the company's core competency in providing specialized scientific expertise to FDA divisions, particularly those engaged in regulatory science, drug development, and medical product safety. Midnight Sun Technologies has demonstrated consistent success in securing task orders through this IDIQ, supporting critical FDA programs including the Center for Biologics Evaluation and Research and the Division of Cellular and Gene Therapies through various labor categories including Scientists, Researchers, and Bioinformaticists.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($87k) | 1/21/26 | |
| P00001 | Terminate for Convenience | $0 | 4/15/25 | |
| Not listed | Not listed | $168.6k | 7/24/24 |